D-0629-2021 Class III Terminated

Recalled by Dr. Reddy's Laboratories, Inc. — Princeton, NJ

FDA drug recall D-0629-2021 was initiated by Dr. Reddy's Laboratories, Inc. on Jun 4, 2021 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: due to presence of ATV cyclo IP and FP impurities The recall status is terminated (terminated Feb 16, 2023). Affected quantity: 5984 bottles.

Recall details

Product Type
Drugs
Report Date
Jun 23, 2021
Initiation Date
Jun 4, 2021
Termination Date
Feb 16, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
5984 bottles

Product description

Atorvastatin Calcium Tablets, USP 10 mg, 500-count bottles, Rx Only, Dr. Reddy's Mfd. By: Dr. Reddy's Laboratories Limited, Bachupally, 500-090 India, NDC 55111-121-05.

Reason for recall

Failed Impurities/Degradation Specifications: due to presence of ATV cyclo IP and FP impurities

Distribution pattern

Nationwide within the United States

Code information

Lot #: C905064, C905065, Exp. Date 07/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0629-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0629-2021. Report a data issue: hello@regdatalab.com.